News
Health on MSN4d
What Does Psoriatic Arthritis Feel Like?Psoriatic arthritis is a combination of psoriasis and arthritis symptoms. You may have skin and nail changes, joint pain and ...
Long-term extension data show Tremfya (guselkumab) significantly reduced symptoms and inhibited structural joint damage ...
Psoriatic arthritis represents a complex intersection of immune dysfunction where inflammation targets both skin and joints, ...
While pharmacologic therapies remain central to managing PsO and PsA, non-pharmacologic interventions also play a crucial ...
Clinical Trials Arena on MSN3d
J&J’s psoriatic arthritis therapy trial meets endpointsJohnson & Johnson has reported positive results from a Phase IIIb trial of Tremfya (guselkumab) for active psoriatic ...
Johnson & Johnson (NYSE:JNJ) on Friday announced topline results from Phase 3b APEX study of Tremfya (guselkumab) in patients ...
9don MSN
Delays in diagnosing and treating psoriatic arthritis—a common inflammatory disorder affecting around 200,000 people in the U ...
Long-term extension analysis of the phase 3b APEX study (NCT04882098) through 3 years of treatment will further assess the ...
Johnson & Johnson announces positive results from phase 3b APEX study of Tremfya to treat adults living with active psoriatic arthritis: Spring House, Pennsylvania Monday, April 7 ...
Johnson & Johnson (JNJ) reports a Phase 3 success for its anti-inflammatory drug Tremfya in treating psoriatic arthritis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback